Skip to content

Tert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate

C25H27N5O2S — CID 117075015

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACtert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate
SMILESCC(C)(C)OC(=O)N1CCC(c2nc(-c3nc4ccc(-c5ccncc5)cc4[nH]3)cs2)CC1
InChIInChI=1S/C25H27N5O2S/c1-25(2,3)32-24(31)30-12-8-17(9-13-30)23-29-21(15-33-23)22-27-19-5-4-18(14-20(19)28-22)16-6-10-26-11-7-16/h4-7,10-11,14-15,17H,8-9,12-13H2,1-3H3,(H,27,28)
InChIKeyZUXPMUMVDSNXDD-UHFFFAOYSA-N
MW461.59 g/mol
LogP5.86
Rot. Bonds3

About Tert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate

Tert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate (PubChem CID 117075015) has the molecular formula C25H27N5O2S and a molecular weight of 461.59 g/mol. Its IUPAC name is tert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate.

Molecular Properties

Compound NameTert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate
PubChem CID117075015
Molecular FormulaC25H27N5O2S
Molecular Weight461.59 g/mol
Exact Mass461.19
IUPAC Nametert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate
SMILESCC(C)(C)OC(=O)N1CCC(c2nc(-c3nc4ccc(-c5ccncc5)cc4[nH]3)cs2)CC1
InChIInChI=1S/C25H27N5O2S/c1-25(2,3)32-24(31)30-12-8-17(9-13-30)23-29-21(15-33-23)22-27-19-5-4-18(14-20(19)28-22)16-6-10-26-11-7-16/h4-7,10-11,14-15,17H,8-9,12-13H2,1-3H3,(H,27,28)
InChIKeyZUXPMUMVDSNXDD-UHFFFAOYSA-N
XLogP5.86
TPSA84.00 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds3
Heavy Atoms33
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500461.59
LogP ≤ 55.86
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze Tert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Tert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate?
The IUPAC name of Tert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate (CID 117075015) is tert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate.
What is the SMILES notation for Tert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate?
The canonical SMILES for Tert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate is CC(C)(C)OC(=O)N1CCC(c2nc(-c3nc4ccc(-c5ccncc5)cc4[nH]3)cs2)CC1.
What is the InChIKey of Tert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate?
The InChIKey is ZUXPMUMVDSNXDD-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H27N5O2S/c1-25(2,3)32-24(31)30-12-8-17(9-13-30)23-29-21(15-33-23)22-27-19-5-4-18(14-20(19)28-22)16-6-10-26-11-7-16/h4-7,10-11,14-15,17H,8-9,12-13H2,1-3H3,(H,27,28).
What are the key properties of Tert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate?
Tert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate has a molecular weight of 461.59 g/mol, XLogP of 5.86, 3 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for Tert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate is sourced from PubChem (CID 117075015), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.